We review these patients’ diagnoses, molecular profiling results, and management in the context of the literature to demonstrate the importance of BAP1 tumor testing in meningioma with rhabdoid features regardless of grade, germline testing for patients with BAP1 inactivated tumors, and tailored cancer screening in this population. This evidence concerns the gene BAP1 and cancer.